Ramsey Quantitative Systems acquired a new position in shares of Nu Skin Enterprises, Inc. (NYSE:NUS) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 5,632 shares of the company’s stock, valued at approximately $354,000.

Several other large investors have also added to or reduced their stakes in NUS. ProShare Advisors LLC bought a new position in shares of Nu Skin Enterprises during the 1st quarter worth about $245,000. Russell Investments Group Ltd. lifted its holdings in shares of Nu Skin Enterprises by 15.0% during the 1st quarter. Russell Investments Group Ltd. now owns 74,166 shares of the company’s stock worth $4,122,000 after acquiring an additional 9,693 shares during the period. Great West Life Assurance Co. Can lifted its holdings in shares of Nu Skin Enterprises by 405.5% during the 1st quarter. Great West Life Assurance Co. Can now owns 29,728 shares of the company’s stock worth $1,650,000 after acquiring an additional 23,847 shares during the period. LSV Asset Management bought a new position in shares of Nu Skin Enterprises during the 1st quarter worth about $283,000. Finally, Bank of New York Mellon Corp lifted its holdings in shares of Nu Skin Enterprises by 91.5% during the 1st quarter. Bank of New York Mellon Corp now owns 724,762 shares of the company’s stock worth $40,253,000 after acquiring an additional 346,236 shares during the period. 79.25% of the stock is owned by institutional investors.

A number of equities analysts have recently commented on the stock. TheStreet raised shares of Nu Skin Enterprises from a “c+” rating to a “b” rating in a report on Wednesday, August 2nd. Stifel Nicolaus set a $50.00 price objective on shares of Nu Skin Enterprises and gave the stock a “sell” rating in a report on Thursday, August 3rd. Zacks Investment Research downgraded shares of Nu Skin Enterprises from a “hold” rating to a “sell” rating in a report on Saturday, June 24th. ValuEngine raised shares of Nu Skin Enterprises from a “hold” rating to a “buy” rating in a report on Friday, June 2nd. Finally, Pivotal Research reaffirmed a “buy” rating and set a $80.00 price objective (up from $65.00) on shares of Nu Skin Enterprises in a report on Thursday, June 22nd. Two analysts have rated the stock with a sell rating, two have issued a hold rating and five have given a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $62.00.

Shares of Nu Skin Enterprises, Inc. (NUS) traded up 0.59% during trading on Friday, reaching $61.46. 166,401 shares of the company traded hands. Nu Skin Enterprises, Inc. has a 12 month low of $46.35 and a 12 month high of $66.04. The company has a 50-day moving average of $60.27 and a 200-day moving average of $58.09. The stock has a market capitalization of $3.25 billion, a PE ratio of 20.56 and a beta of 1.37.

Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings data on Wednesday, August 2nd. The company reported $0.77 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.69 by $0.08. Nu Skin Enterprises had a net margin of 7.53% and a return on equity of 24.14%. The business had revenue of $550.10 million during the quarter, compared to analysts’ expectations of $548.09 million. During the same quarter in the prior year, the business posted $0.79 earnings per share. Nu Skin Enterprises’s revenue was down 8.4% compared to the same quarter last year. Analysts forecast that Nu Skin Enterprises, Inc. will post $3.23 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 13th. Investors of record on Friday, August 25th were given a dividend of $0.36 per share. The ex-dividend date was Wednesday, August 23rd. This represents a $1.44 annualized dividend and a yield of 2.34%. Nu Skin Enterprises’s dividend payout ratio is 48.81%.

In related news, General Counsel D Matthew Dorny sold 8,250 shares of the company’s stock in a transaction dated Wednesday, July 5th. The shares were sold at an average price of $62.92, for a total transaction of $519,090.00. Following the completion of the sale, the general counsel now owns 46,730 shares of the company’s stock, valued at $2,940,251.60. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Daniel W. Campbell sold 4,607 shares of the company’s stock in a transaction dated Thursday, September 7th. The stock was sold at an average price of $62.48, for a total transaction of $287,845.36. Following the sale, the director now directly owns 63,753 shares of the company’s stock, valued at approximately $3,983,287.44. The disclosure for this sale can be found here. Insiders have sold 28,357 shares of company stock valued at $1,783,535 in the last ninety days. 5.20% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION NOTICE: “Ramsey Quantitative Systems Acquires Shares of 5,632 Nu Skin Enterprises, Inc. (NUS)” was first posted by Watch List News and is owned by of Watch List News. If you are reading this report on another site, it was stolen and reposted in violation of US & international copyright law. The legal version of this report can be accessed at https://www.watchlistnews.com/ramsey-quantitative-systems-acquires-shares-of-5632-nu-skin-enterprises-inc-nus/1585206.html.

Nu Skin Enterprises Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).

Institutional Ownership by Quarter for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.